Nymox Pharmaceutical Corp
NYMX
Market Cap$0
Close$
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-509,000.00 |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-0.15 |
| Beta | 0.0 |
| Outstanding Shares | 90,515,140 |
| Avg 30 Day Volume | 0 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0.0 |
|---|---|
| PEG | -0.0 |
| Price to Sales | - |
| Price to Book Ratio | -0.2 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0.04 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.73 |
| Debt to Equity | -30.92 |
Revenue Sources
No data
ESG Score
No data